Radiation Therapy Equipment

Radiation Therapy Equipment

Global Radiation Therapy Equipment Market to Reach US$9.5 Billion by 2030

The global market for Radiation Therapy Equipment estimated at US$6.1 Billion in the year 2023, is expected to reach US$9.5 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. External Beam Radiation Therapy Equipment, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.1 Billion by the end of the analysis period. Growth in the Internal Radiation Therapy Equipment segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 8.6% CAGR

The Radiation Therapy Equipment market in the U.S. is estimated at US$2.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$865.9 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Global Radiation Therapy Equipment Market - Key Trends & Drivers Summarized

Radiation therapy equipment is critical in the treatment of cancer, utilizing high-energy radiation to target and destroy malignant cells while minimizing damage to surrounding healthy tissues. The primary types of radiation therapy equipment include linear accelerators (LINACs), brachytherapy devices, and proton therapy systems. LINACs are the most widely used devices, producing high-energy x-rays or electrons that are precisely directed at cancerous tumors. Brachytherapy involves placing radioactive sources directly inside or next to the tumor, providing a high radiation dose to the cancer cells while sparing healthy tissue. Proton therapy systems use protons instead of x-rays, offering a more targeted approach that is particularly beneficial for treating tumors located near critical structures.

Technological advancements have significantly enhanced the precision, effectiveness, and safety of radiation therapy equipment. Innovations such as image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) have allowed for more accurate targeting of tumors, reducing side effects and improving patient outcomes. The integration of artificial intelligence (AI) and machine learning into radiation therapy planning and delivery has further optimized treatment protocols, enabling personalized therapy plans based on individual patient anatomy and tumor characteristics. Additionally, the development of compact and cost-effective proton therapy systems has expanded the accessibility of this advanced treatment modality, allowing more healthcare facilities to offer state-of-the-art cancer care.

The growth in the radiation therapy equipment market is driven by several factors, including the increasing prevalence of cancer, advancements in radiation therapy technologies, and rising investments in healthcare infrastructure. The global rise in cancer incidence has heightened the demand for effective treatment options, thereby boosting the adoption of advanced radiation therapy equipment. Continuous technological advancements, such as the development of more precise and efficient radiation delivery systems, have expanded the applications and efficacy of radiation therapy. Additionally, increasing investments in healthcare infrastructure, particularly in emerging markets, are facilitating the establishment of new cancer treatment centers equipped with modern radiation therapy devices. Government initiatives and funding aimed at improving cancer care and increasing access to advanced treatment options are also contributing to market growth.

Select Competitors (Total 57 Featured) -

• Hitachi Ltd.
• GE HealthCare PLC
• Hologic, Inc.
• Elekta AB
• Brainlab AG
• Accuray, Inc.
• IsoRay Medical, Inc.
• C-RAD AB
• Acceletronics, Inc.
• Bionix Development Corporation
• Best Medical International, Inc.
• Huiheng Medical, Inc.
• IBA Worldwide
• .decimal, Inc.
• Canon Medical Systems Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.